A number of randomized clinical trials now support the conclusion that the combined-modality regimen that includes gemcitabine (Gemzar) and cisplatin (Platinol) may improve survival in disseminated non-small-cell lung
Antonio Maestri, MD
Advertisement
Articles by Antonio Maestri, MD
Advertisement
Latest Updated Articles
- Gemcitabine and Cisplatin Combination in Early-Stage Non-Small-Cell Lung Cancer
Published: March 3rd 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Managing BCMA/GPRC5D-Associated CRS and ICANS in the Real-World Setting
2
Adjuvant Endocrine/Radiation Therapy May Limit Breast Cancer Recurrence
3
Cryoablation Regimen Receives FDA Marketing Authorization for Breast Cancer
4
Addressing Early Talquetamab Toxicity Concerns
5
